Search app
CSR Racing 2

Oncology Nursing Drug Handbook

Medical & Education
Last Update
Jul 20, 2021
View in store

Store Performance Index


Store Performance Index shows overall performance of your app on app stores. It is based on combined ASO & reviews metrics.

See more data

Ratings & Reviews performance for Oncology Nursing Drug Handbook

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,


Avg rating,



2543 chars

2018 Oncology Nursing Drug Handbook. Written especially for nurses caring for patients with cancer. Download the FREE app and view selected topics (Approximately 10% of the content is viewable in the free app and tapping on the locked topic will launch the in-app purchase screen). The 2018 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2017 Oncology Nursing Drug Handbook includes separate chapters on molecular and immunologic/biologic targeted therapies. These chapters provide fundamental reviews to assist nurses in understanding the cellular communication pathways disrupted by cancer. It also offers simplified content, attention to understanding the immune checkpoint inhibitors, new information about immunotherapy, new drugs and their indications, and updated indications and side effects for recently FDA approved drugs. New drugs include: alectinib (Alecensa), atezolizumab (Tecentriq), cabozantinib tablets (Cabometyx), cabozantinib capsules (Cometriq), cobimetinib tablets (Cotellic), colistin/polymixin B, clotrimazole, daratumumab (Darzalex), elotuzumab (Empliciti), irinotecan liposome injection (Onivyde), ixazomib (Ninlaro), melphalan for injection (Evoela), necitumumab (Portrazza), osimertinib (Targrisso), pentamidine, posaconazole, peramivir, rolapitant (Varubi) , talimogene laherparepvec (Imlygic), Tamiflu, trabectedin (Yondelis), uridine triacetate (Vistogard granules), venetoclax (Venclexta), vincristine liposome injection (Marqibo), and zanamivir. Table of Content: I Cancer Treatment 1 Introduction to Chemotherapy Drugs 2 Biologic Response Modifier Therapy 3 Cytoprotective Agents 4 Molecularly Targeted Therapies 5 Chemobiotherapy for Noncancer Diseases II Symptom Management 6 Pain 7 Nausea and Vomiting 8 Anorexia and Cachexia 9 Anxiety and Depression III Complications 10 Managing Tumor-Related Skeletal Events and Hypercalcemia 11 Infection 12 Constipation 13 Diarrhea Appendix 1 : Occupational Exposure to Hazardous Drugs Appendix 2 :Common Terminology Criteria for Adverse Events (CTCAE) Author: Gail M. Wilkes, MS, APRN-BC, AOCN-Oncology Nursing Consultant, Kilauea, Hawaii ISBN-13: 9781284117189 ISBN-10:1284117189

 Why to reply to reviews?

User reviews affect conversion to installs and app rating. Featured and helpful reviews are the first to be noticed by users and in case of no response can affect download rate. This is why it is highly recommended to reply to them.

Jan 16, 2019

The content on this app looks to be useful and I recognize the author names from other oncology nursing resources, which increases my trust. However: does the $60 “lifetime access” fee include automatic content updates? Otherwise, it hardly seems worthwhile. Thanks!

Jan 06, 2020

Not useful without paying 59.99 for basically any content you click on.

CSR Racing 2

About Oncology Nursing Drug Handbook

Developed by Skyscape Medpresso Inc.

Oncology Nursing Drug Handbook is ranking in   Medical & Education

Last update was at Jul 20, 2021and the current version is 4.4.1.

To see all other keys and revenue click here 1298511926

Oncology Nursing Drug Handbook have a 2a user reviews.

Oncology Nursing Drug Handbook was released in the App Store. It is developed by Skyscape Medpresso Inc, who have also released the following apps.

Oncology Nursing Drug Handbook has 2 user reviews.​

Oncology Nursing Drug Handbook has an average rating of 3.5. ​The latest version of Oncology Nursing Drug Handbook 4.4.1​ ​​was ​released on Jul 20, 2021​.

You can download Oncology Nursing Drug Handbook ​here

Find growth insights on our blog

How to Respond to Google Play Reviews

How to Respond to Google Play Reviews

How to Respond to App Store Reviews

How to Respond to App Store Reviews

AppFollow identifies top apps in the App Store and Google Play in 2020

AppFollow identifies top apps in the App Store and Google Play in 2020

React to user feedback and market trends faster